These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15285980)

  • 21. Relationships between white matter metabolite abnormalities, cognitive and social functioning in elderly schizophrenic subjects.
    Friedman JI; Davis KL; Chang L; Ernst T; Tsopelas ND; Zhong K
    Schizophr Res; 2008 Mar; 100(1-3):356-8. PubMed ID: 18042350
    [No Abstract]   [Full Text] [Related]  

  • 22. Health-related quality of life and functioning of middle-aged and elderly adults with bipolar disorder.
    Depp CA; Davis CE; Mittal D; Patterson TL; Jeste DV
    J Clin Psychiatry; 2006 Feb; 67(2):215-21. PubMed ID: 16566616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurocognitive impairment in middle-aged and older adults with bipolar disorder: comparison to schizophrenia and normal comparison subjects.
    Depp CA; Moore DJ; Sitzer D; Palmer BW; Eyler LT; Roesch S; Lebowitz BD; Jeste DV
    J Affect Disord; 2007 Aug; 101(1-3):201-9. PubMed ID: 17224185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Characteristics and impact of metacognitive deficits in schizophrenia].
    Quiles C; Prouteau A; Verdoux H
    Encephale; 2013 Apr; 39(2):123-9. PubMed ID: 23219408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One-year functional outcomes of naturalistically treated patients with schizophrenia.
    Spellmann I; Riedel M; Schennach R; Seemüller F; Obermeier M; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ
    Psychiatry Res; 2012 Aug; 198(3):378-85. PubMed ID: 22421065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remission in schizophrenia: results from a 1-year follow-up observational study.
    Ciudad A; Alvarez E; Bobes J; San L; Polavieja P; Gilaberte I
    Schizophr Res; 2009 Mar; 108(1-3):214-22. PubMed ID: 19168329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of symptomatic remission with quality of life and functionality in patients with schizophrenia.
    Karadayi G; Emiroğlu B; Uçok A
    Compr Psychiatry; 2011; 52(6):701-7. PubMed ID: 21296345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlates of health-related quality of well-being in older patients with schizophrenia.
    Mittal D; Davis CE; Depp C; Pyne JM; Golshan S; Patterson TL; Jeste DV
    J Nerv Ment Dis; 2006 May; 194(5):335-40. PubMed ID: 16699382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Schizoaffective disorder: a form of schizophrenia or affective disorder?
    Evans JD; Heaton RK; Paulsen JS; McAdams LA; Heaton SC; Jeste DV
    J Clin Psychiatry; 1999 Dec; 60(12):874-82. PubMed ID: 10665641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Quality of life in patients with schizophrenia: a study of 100 cases].
    Zouari L; Thabet JB; Elloumi Z; Elleuch M; Zouari N; Maâlej M
    Encephale; 2012 Apr; 38(2):111-7. PubMed ID: 22516268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Symptomatic remission and neurocognitive functioning in patients with schizophrenia.
    Hofer A; Bodner T; Kaufmann A; Kemmler G; Mattarei U; Pfaffenberger NM; Rettenbacher MA; Trebo E; Yalcin N; Fleischhacker WW
    Psychol Med; 2011 Oct; 41(10):2131-9. PubMed ID: 21426601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age disorientation in schizophrenia: an indicator of progressive and severe psychopathology, not institutional isolation.
    Manschreck TC; Maher BA; Winzig L; Candela SF; Beaudette S; Boshes R
    J Neuropsychiatry Clin Neurosci; 2000; 12(3):350-8. PubMed ID: 10956568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substance abuse and cognitive functioning in schizophrenia.
    Addington J; Addington D
    J Psychiatry Neurosci; 1997 Mar; 22(2):99-104. PubMed ID: 9074303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of a functional remission threshold for the Functional Remission of General Schizophrenia (FROGS) scale.
    Boyer L; Richieri R; Guedj E; Faget-Agius C; Loundou A; Llorca PM; Auquier P; Lançon C
    Compr Psychiatry; 2013 Oct; 54(7):1016-22. PubMed ID: 23731897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of functional remission in schizophrenic disorder. The FROGS Scale].
    Rouillon F; Baylé FJ; Gorwood P; Lancrenon S; Lançon C; Llorca PM;
    Encephale; 2013 May; 39 Suppl 1():S15-21. PubMed ID: 23541143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive deficits and psychopathology in institutionalized versus community-dwelling elderly schizophrenia patients.
    Evans JD; Negron AE; Palmer BW; Paulsen JS; Heaton RK; Jeste DV
    J Geriatr Psychiatry Neurol; 1999; 12(1):11-5. PubMed ID: 10447149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symptom remission in first episode patients.
    Addington J; Addington D
    Schizophr Res; 2008 Dec; 106(2-3):281-5. PubMed ID: 18926666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability of cognitive performance in older patients with schizophrenia: an 8-week test-retest study.
    Harvey PD; Palmer BW; Heaton RK; Mohamed S; Kennedy J; Brickman A
    Am J Psychiatry; 2005 Jan; 162(1):110-7. PubMed ID: 15625208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder.
    Jabben N; Arts B; van Os J; Krabbendam L
    J Clin Psychiatry; 2010 Jun; 71(6):764-74. PubMed ID: 20122370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The independent living scales as a measure of functional outcome for schizophrenia.
    Revheim N; Medalia A
    Psychiatr Serv; 2004 Sep; 55(9):1052-4. PubMed ID: 15345767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.